SHENYANG, China, June 28 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc.
(Nasdaq: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that on June 25, 2010, the Company has filed with the United States Securities and Exchange Commission its Annual Report on Form 20-F for the year ended December 31, 2009 (the "2009 Annual Report"). The 2009 Annual Report is available at the SEC's website ( http://www.sec.gov ), the Company's website ( http://www.3sbio.com ) or http://tinyurl.com/3Sbio2009
Hard copies of the 2009 Annual Report are available free of charge to our shareholders and ADS holders, upon written request by contacting ir@3SBio.com.
For more information, please contact:
Investor Contacts
Bo Tan
Chief Financial Officer
3SBio Inc.
Tel: +86-24-2581-1820
Email: ir@3SBio.com
Tom Folinsbee
Director of Investor Relations
3SBio Inc.
Tel: +852-8191-6991
Email: ir@3SBio.com